SETD3 Human Pre-designed siRNA Set A contains three designed siRNAs for SETD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SETD4 Human Pre-designed siRNA Set A contains three designed siRNAs for SETD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SETD5 Human Pre-designed siRNA Set A contains three designed siRNAs for SETD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SETD6 Human Pre-designed siRNA Set A contains three designed siRNAs for SETD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SETD7 Human Pre-designed siRNA Set A contains three designed siRNAs for SETD7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SETDB1 Human Pre-designed siRNA Set A contains three designed siRNAs for SETDB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SETDB2 Human Pre-designed siRNA Set A contains three designed siRNAs for SETDB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Setileuton (MK-0633) is an inhibitor for 5-lipoxygenase, that inhibits the oxidation of arachidonic acid by recombinant human 5-LO, and the production of LTB4 in calcium ionophore-stimulated human whole blood, with IC50 of 3.9 and 52 nM, respectively[1].

SETMAR Human Pre-designed siRNA Set A contains three designed siRNAs for SETMAR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SETSIP Human Pre-designed siRNA Set A contains three designed siRNAs for SETSIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SETX Human Pre-designed siRNA Set A contains three designed siRNAs for SETX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEZ6 Human Pre-designed siRNA Set A contains three designed siRNAs for SEZ6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEZ6L Human Pre-designed siRNA Set A contains three designed siRNAs for SEZ6L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SEZ6L2 Human Pre-designed siRNA Set A contains three designed siRNAs for SEZ6L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF-C5-TPP is an potent mitochondria-targeted protonophoric uncoupler. SF-C5-TPP has significant proton transfer activity on model planar bilayer lipid membranes. SF-C5-TPP inhibits the growth of Bacillus subtilis with a MIC of 2 μM>[1].

SF1 Human Pre-designed siRNA Set A contains three designed siRNAs for SF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3A1 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3A2 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3A3 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3A3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3B1 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3B2 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3B2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3B3 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3B3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3B4 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3B4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3B5 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3B5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF3B6 Human Pre-designed siRNA Set A contains three designed siRNAs for SF3B6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SF5 (2,2-Diphenylethyl isothiocyanate) is a sulforaphane analog. SF5 inhibits apoptosis by the JNK-p53-caspase pathway. SF5 can be used as a new renal protective agent for drug-resistant acute renal disease[1].

SF5 (2,2-Diphenylethyl isothiocyanate) is a sulforaphane analog. SF5 inhibits apoptosis by the JNK-p53-caspase pathway. SF5 can be used as a new renal protective agent for drug-resistant acute renal disease[1].

SF5 (2,2-Diphenylethyl isothiocyanate) is a sulforaphane analog. SF5 inhibits apoptosis by the JNK-p53-caspase pathway. SF5 can be used as a new renal protective agent for drug-resistant acute renal disease[1].

SF5 (2,2-Diphenylethyl isothiocyanate) is a sulforaphane analog. SF5 inhibits apoptosis by the JNK-p53-caspase pathway. SF5 can be used as a new renal protective agent for drug-resistant acute renal disease[1].

SF5 (2,2-Diphenylethyl isothiocyanate) is a sulforaphane analog. SF5 inhibits apoptosis by the JNK-p53-caspase pathway. SF5 can be used as a new renal protective agent for drug-resistant acute renal disease[1].

SFB-AMD3465 is an AMD3465 (HY-15971A) derivative. SFB-AMD3465 is utilized as positron emission tomography (PET) tracer for CXCR4, when labeled with radioactive Fluorine[1].

SFI1 Human Pre-designed siRNA Set A contains three designed siRNAs for SFI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SFMBT1 Human Pre-designed siRNA Set A contains three designed siRNAs for SFMBT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SFMBT2 Human Pre-designed siRNA Set A contains three designed siRNAs for SFMBT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SFN Human Pre-designed siRNA Set A contains three designed siRNAs for SFN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SFPQ Human Pre-designed siRNA Set A contains three designed siRNAs for SFPQ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SFR1 Human Pre-designed siRNA Set A contains three designed siRNAs for SFR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SFRP1 Human Pre-designed siRNA Set A contains three designed siRNAs for SFRP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sfrp1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sfrp1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sfrp1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sfrp1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

SFRP2 Human Pre-designed siRNA Set A contains three designed siRNAs for SFRP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.